Parkinson's disease
UK Startup ESP Diagnostics Eyes 2023 Launch for Early-Stage Parkinson's, Lewy Body Dementia Test
Premium
To accelerate diagnostic development, the Newcastle-based firm recently snagged a £272,000 Innovate UK grant.
Amprion Wins Additional $730K NIH Grant to Validate Parkinson's Disease Test
The recently launched test is designed to detect a-synuclein aggregates to aid in the diagnosis of Parkinson's disease and other brain conditions.
The firm obtained FDA breakthrough device designation in 2019 for its protein misfolding cyclic amplification technology and SynTap assay.
Valted Seq Raises $10.5M Seed Funding
The firm will put the funding toward its HiF-Seq single-cell sequencing platform, which will be used to interrogate neurodegenerative disease samples.
Valted Seq Lands Exclusive Rights to Evaluate Johns Hopkins Neurodegenerative Disease Dx Assays
The biomarker assays could one day be used as companion diagnostics for new treatments of Parkinson's and related diseases.
Jul 17, 2019
Aug 15, 2018
Sep 15, 2017
Jul 12, 2017